Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic Effects of Propofol, Sevoflurane, and Isoflurane in Cardiac Surgery
NCT05695287Phase 1Completed
- Sponsor
- Astana Medical University
- Start
- Jan 2021
- Primary completion
- Nov 2022
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 1, randomised trial of propofol injection (veterinary), sevoflurane and isoflurane in coronary artery disease (CAD), mitral valve insufficiency (MR) and aortic valve insufficiency (AI) (3 arms), sponsored by Astana Medical University. Primary endpoints: Cardiac Index, Oxygen Consumption (VO2) and 2 more. Started Jan 2021; status: completed.
02
Drugs
propofol injection (veterinary)sevofluraneisoflurane
03
Conditions
coronary artery disease (CAD)mitral valve insufficiency (MR)aortic valve insufficiency (AI)
Beyond the preview
Go deeper on NCT05695287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05695287.